Clinical trials
Phase 2 Osteoporosis, Postmenopausal trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 4 |
| 2011 | 2 |
| 2012 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 3 |
| Terminated | 2 |
| Not yet recruiting | 2 |
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 4 |
| Merck Sharp & Dohme LLC | 3 |
| Angitia Biopharmaceuticals | 1 |
| Columbia University | 1 |
| Dana-Farber Cancer Institute | 1 |
| Emory University | 1 |
| Fujian Academy of Traditional Chinese Medicine | 1 |
| Martin Blomberg Jensen | 1 |
| Massachusetts General Hospital | 1 |
| National Center for Complementary and Integrative Health (NCCIH) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoporosis, Postmenopausal | 31 |
| Osteoporosis | 13 |
| Bone Diseases, Metabolic | 5 |
| Bone Diseases | 3 |
| Musculoskeletal Diseases | 2 |
| Bone Resorption | 1 |
| Breast Neoplasms | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Hot Flashes | 1 |
Trials
Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.